Inhibiting Biofilm Formation

  • ChemPubSoc Europe Logo
  • Author: ChemViews
  • Published Date: 13 November 2011
  • Source / Publisher: ChemBioChem/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
thumbnail image: Inhibiting Biofilm Formation

Related Societies

Bacteria growing in biofilms are often in metabolic and physiological states that do not respond well to antibiotics, and thus, are major contributors to chronic diseases. For example, Pseudomonas aeruginosa is a prominent cause of chronic infections in people with cystic fibrosis, immunecompromised patients, and burn victims. Biofilm inhibitors have the potential to be used alone or as adjuvants to conventional antibiotic therapies.

Lori Burrows and co-workers, McMaster University, Hamilton, Canada, have screened protein kinase inhibitors for molecules that modulate biofilm development. The screen revealed that the protein kinase C inhibitor, palmitoyl-dl-carnitine (pdlc, pictured), blocks biofilm formation by the pathogen P. aeruginosa. The molecule stimulates motility, blocks quorum sensing and overrides at least two biofilm-stimulatory cues.
This class of compound has potential utility as an antibiotic adjuvant, not only by blocking aminoglycoside-mediated biofilm stimulation but also by preventing bacteria from entering a biofilm state that is tolerant of conventional antimicrobials. Since pdlc blocks biofilm formation by a combination of mechanisms, resistance to its effects is less likely to arise.

Article Views: 2559

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from, please contact us first for permission. more

CONNECT: on Facebook on Twitter on YouTube on LinkedIn Sign up for our free newsletter

A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH